Blog

by Heidi Hagen and Christophe Suchet | February 21, 2020
This post is the eighth in an eight-part series on data management strategies for personalized therapeutics, such as cell therapies, gene therapies, or neoantigen cancer vaccines.

by Heidi Hagen and Christophe Suchet | February 19, 2020
This post is the seventh in an eight-part series on data management strategies for personalized therapeutics, such as cell therapies, gene therapies, or neoantigen cancer vaccines.

by Heidi Hagen and Christophe Suchet | February 12, 2020
This post is the sixth in an eight-part series on data management strategies for personalized therapeutics, such as cell therapies, gene therapies, or neoantigen cancer vaccines.

by Heidi Hagen and Christophe Suchet | February 11, 2020
This post is the fifth in an eight-part series on data management strategies for personalized therapeutics, such as cell therapies, gene therapies, or neoantigen cancer vaccines.

by Nina Kjellson, Laura Chau, and Amy DuRoss | December 17, 2019
Canaan investors, an early-stage venture capital firm that partners with founders to build the future of how we live, work and thrive. Each episode we share the journeys and wisdom of remarkable women working in life science, technology and business.…

  • 1 (current)
  • 2
  • 3
Subscribe to our blog
Required
Required
Required
Required
Required
Required
Required
Required